Advances in long non-coding RNA regulating drug resistance of cancer

作者：Ying Zhang, Sun Wenjing, Bai Jing, Songbin Fu, Dong Kexian · 发表于：Gene · 年份：2023 · DOI：10.1016/j.gene.2023.147726 · 被引用次数：11 · 研究领域：Cancer-related molecular mechanisms research、MicroRNA in disease regulation、Mycobacterium research and diagnosis

Drug resistance is one of the main challenges in cancer treatment. Long non coding RNAs (lncRNAs) play a complex and precise regulatory role in regulating drug resistance of cancer. The common ways of lncRNA regulating drug resistance of cancer involve ATP binding transporter overexpression, abnormal DNA damage response, tumor cell apoptosis, accumulation of epithelial mesenchymal transformation and cancer stem cell formation. Moreover, studies on exosomal lncRNAs regulating cancer drug resistance are developed in recent years. Further study on the role and mechanism of lncRNAs drug resistance in cancer will help clinical cancer treatment program and explore new treatment methods. This paper reviews recent advances in lncRNAs regulating drug resistance of cancer, especially the role of exosomal lncRNAs.